Detalhe da pesquisa
1.
How I treat chronic-phase chronic myelogenous leukemia.
Blood;
139(21): 3138-3147, 2022 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34529784
2.
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
22(1): 43-69, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38394770
3.
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Am J Hematol;
98(12): 1869-1876, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37688521
4.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med;
381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31665578
5.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood;
136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32688395
6.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Cancer;
127(23): 4421-4431, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34424530
7.
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
18(10): 1385-1415, 2020 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33022644
8.
Leukaemogenesis induced by an activating ß-catenin mutation in osteoblasts.
Nature;
506(7487): 240-4, 2014 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24429522
9.
Pregnancy in Patients With Chronic Myeloid Leukemia.
J Natl Compr Canc Netw;
16(5S): 660-662, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29784750
10.
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
16(9): 1108-1135, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30181422
11.
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.
Blood;
124(18): 2834-46, 2014 Oct 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25139351
12.
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.
J Natl Compr Canc Netw;
14(12): 1505-1512, 2016 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27956535
13.
Where exactly does ponatinib fit in chronic myelogenous leukemia?
J Natl Compr Canc Netw;
12(11): 1615-20, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25361807
14.
Chronic myelogenous leukemia, version 1.2015.
J Natl Compr Canc Netw;
12(11): 1590-610, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25361806
15.
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia.
Blood;
118(23): 6030-6, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21976672
16.
Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms.
Haematologica;
103(1): e5-e9, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29051283
17.
Chronic Myelogenous Leukemia, Version 1.2014.
J Natl Compr Canc Netw;
11(11): 1327-40, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24225967
18.
Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterization.
Eur J Haematol;
90(2): 142-50, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23240881
19.
Genetic mutations in chronic myelogenous leukemia: when to check and what to do?
Curr Opin Hematol;
19(2): 110-6, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22248877
20.
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia.
Curr Hematol Malig Rep;
18(2): 33-39, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36763239